Anticoagulation in Patients with Heart Failure

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 7, Iss. 3, 2009-07 ,pp. : 193-197

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Heart Failure in Real‐World Clinical Practice: Findings From the REFLECT‐HF Registry in Patients With NYHA Class II Symptoms and a Reduced Ejection Fraction

By  

Clinical Cardiology, Vol. 38, Iss. 4, 2015-04 ,pp. : 200-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-coagulants for Prevention

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 53-58

Bentham Science Publishers

Access to resources Recommend Favorite

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter‐Defibrillator for Primary Prevention

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matrix Metalloproteinase Inhibition and the Prevention of Heart Failure

By Lee R.T.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 5, 2001-07 ,pp. : 202-205

Elsevier

Access to resources Recommend Favorite